» Articles » PMID: 22701711

TIMP-1 Induces an EMT-like Phenotypic Conversion in MDCK Cells Independent of Its MMP-inhibitory Domain

Overview
Journal PLoS One
Date 2012 Jun 16
PMID 22701711
Citations 35
Authors
Affiliations
Soon will be listed here.
Abstract

Matrix metalloproteinases (MMPs) and their endogenous inhibitors (TIMPs) regulate epithelial-mesenchymal transition (EMT) critical for the development of epithelial organs as well as cancer cell invasion. TIMP-1 is frequently overexpressed in several types of human cancers and serves as a prognostic marker. The present study investigates the roles of TIMP-1 on the EMT process and formation of the lumen-like structure in a 3D Matrigel culture of MDCK cells. We show that TIMP-1 overexpression effectively prevents cell polarization and acinar-like structure formation. TIMP-1 induces expression of the developmental EMT transcription factors such as SLUG, TWIST, ZEB1 and ZEB2, leading to downregulation of epithelial marker and upregulation of mesenchymal markers. Importantly, TIMP-1's ability to induce the EMT-like process is independent of its MMP-inhibitory domain. To our surprise, TIMP-1 induces migratory and invasive properties in MDCK cells. Here, we present a novel finding that TIMP-1 signaling upregulates MT1-MMP and MMP-2 expression, and potentiates MT1-MMP activation of pro-MMP-2, contributing to tumor cell invasion. In spite of the fact that TIMP-1, as opposed to TIMP-2, does not interact with and inhibit MT1-MMP, TIMP-1 may act as a key regulator of MT1-MMP/MMP-2 axis. Collectively, our findings suggest a model in which TIMP-1 functions as a signaling molecule and also as an endogenous inhibitor of MMPs. This concept represents a paradigm shift in the current view of TIMP-1/MT1-MMP interactions and functions during cancer development/progression.

Citing Articles

Multi-omics analysis reveals that neutrophil extracellular traps related gene TIMP1 promotes CRC progression and influences ferroptosis.

Jin Y, Liao L, Chen Q, Tang B, Jiang J, Zhu J Cancer Cell Int. 2025; 25(1):31.

PMID: 39891145 PMC: 11786501. DOI: 10.1186/s12935-025-03643-y.


Holothurin A Inhibits RUNX1-Enhanced EMT in Metastasis Prostate Cancer via the Akt/JNK and P38 MAPK Signaling Pathway.

Janta S, Pranweerapaiboon K, Vivithanaporn P, Plubrukarn A, Chairoungdua A, Prasertsuksri P Mar Drugs. 2023; 21(6).

PMID: 37367670 PMC: 10301049. DOI: 10.3390/md21060345.


Tissue Inhibitor of Metalloproteinase-1 Enhances Eosinophilic Airway Inflammation in Severe Asthma.

Cao T, Luu Quoc Q, Yang E, Moon J, Shin Y, Ryu M Allergy Asthma Immunol Res. 2023; 15(4):451-472.

PMID: 37075799 PMC: 10359643. DOI: 10.4168/aair.2023.15.4.451.


SLC35A2 Deficiency Promotes an Epithelial-to-Mesenchymal Transition-like Phenotype in Madin-Darby Canine Kidney Cells.

Kot M, Mazurkiewicz E, Wiktor M, Wiertelak W, Mazur A, Rahalevich A Cells. 2022; 11(15).

PMID: 35892570 PMC: 9331475. DOI: 10.3390/cells11152273.


Correlation between the immune checkpoints and EMT genes proposes potential prognostic and therapeutic targets in ESCC.

Mahmoudian R, Mozhgani S, Abbaszadegan M, Mokhlessi L, Montazer M, Gholamin M J Mol Histol. 2021; 52(3):597-609.

PMID: 33884540 DOI: 10.1007/s10735-021-09971-3.


References
1.
Guedez L, Courtemanch L, Stetler-Stevenson M . Tissue inhibitor of metalloproteinase (TIMP)-1 induces differentiation and an antiapoptotic phenotype in germinal center B cells. Blood. 1998; 92(4):1342-9. View

2.
Guedez L, Stetler-Stevenson W, Wolff L, Wang J, Fukushima P, Mansoor A . In vitro suppression of programmed cell death of B cells by tissue inhibitor of metalloproteinases-1. J Clin Invest. 1998; 102(11):2002-10. PMC: 509153. DOI: 10.1172/JCI2881. View

3.
Soulie P, Carrozzino F, Pepper M, Strongin A, Poupon M, Montesano R . Membrane-type-1 matrix metalloproteinase confers tumorigenicity on nonmalignant epithelial cells. Oncogene. 2004; 24(10):1689-97. DOI: 10.1038/sj.onc.1208360. View

4.
Kuvaja P, Talvensaari-Mattila A, Turpeenniemi-Hujanen T . High preoperative plasma TIMP-1 is prognostic for early relapse in primary breast carcinoma. Int J Cancer. 2008; 123(4):846-51. DOI: 10.1002/ijc.23531. View

5.
Hellman N, Spector J, Robinson J, Zuo X, Saunier S, Antignac C . Matrix metalloproteinase 13 (MMP13) and tissue inhibitor of matrix metalloproteinase 1 (TIMP1), regulated by the MAPK pathway, are both necessary for Madin-Darby canine kidney tubulogenesis. J Biol Chem. 2007; 283(7):4272-82. DOI: 10.1074/jbc.M708027200. View